ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

In Brief: Ira Kline, NCI researcher, Dead At 69; Massey Recruits Scientists; ACR Awards

October 15, 1993

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985